Jobs and inflation data will be released late and with caveats, complicating the Federal Reserve’s interest rate ...

Recent government shutdown created data challenges but alternative sources confirm US automotive sector remains strong with ...

New platform converts an established lead-generation system into a scalable intake and data monetization engine targeting the ...

The controversy over President Trump’s proposal for a 50-year mortgage is highlighting deep affordability concerns in the ...

The US government has reopened following its longest-ever shutdown, setting the stage for the eventual release of the gold-standard federal data that is crucial in analyzing the health and trajectory ...

Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena.

The U.S. Labor Department's statistical agency should prioritize the production of November employment and inflation reports ...

Dr. Pineda explains, “The ongoing U.S. government shutdown has created significant hurdles for economists and analysts who ...

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

After a 43-day shutdown, federal agencies like the BLS and BEA may be scrambling to release long-delayed economic data. Experts warn that crucial reports on jobs and inflation could take weeks to ...

The Labor Department will release its numbers on September hiring and unemployment next Thursday, a month and a half late, ...

New platform converts an established lead-generation system into a scalable intake and data monetization engine targeting the underserved and subprime consumer market. Proven legacy software reenginee ...